Geron Corporation (NASDAQ: GERN), StemCells Inc. (NASDAQ: STEM), and Opexa Therapeutics, Inc. (NASDAQ: OPXA) are all playing give-back this morning on the heels of monster gains yesterday due to the National Institutes of Health approving new embryonic stem cell lines.
At 8:39 AM EST we have GERN down 2.9% at $6.02 on 80,000 shares, STEM down 5.4% at $1.40 on 695,000 shares, and OPXA is down 10% at $2.86 on 35,000 shares. As a reminder, the NIH did say that it would be making a new announcement on stem cell line approvals after 96 lines were submitted…. and that deadline is tomorrow, so these may all swing wildly yet again.
JON C. OGG
No comments:
Post a Comment